Towards Healthcare
Gene Therapy Cell Culture Media Market to Rise USD 214.42 Bn by 2034

Gene Therapy Cell Culture Media Market Driving Biotech Advances

According to market projections, the gene therapy cell culture media sector is expected to grow from USD 193.45 billion in 2024 to USD 541.42 billion by 2034, reflecting a CAGR of 10.84%. The market is growing due to rising demand for efficient gene-based treatments and the increasing number of clinical trials. Advancements in media formulations that enhance cell growth and vector production are fueling North America’s expansion. 

  • Insight Code: 6089
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The gene therapy cell culture media market in 2025 is valued at USD 214.42 billion and is projected to climb to USD 541.42 billion by 2034, with a CAGR of 10.84% over the forecast period.

North America is currently leading the gene therapy cell culture media market due to its advanced healthcare infrastructure and concentration of major biopharmaceutical and biotechnology companies.

Some key players include Thermo Fisher Scientific, Lonza, Merck / MilliporeSigma, FUJIFILM Irvine Scientific, Cytiva, Takara Bio, and BioLife Solutions.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.